QHC Letters Preview Final Guidance; “Read Them,” Stresses Schneeman
This article was originally published in The Tan Sheet
Executive Summary
FDA's letters of enforcement discretion offer industry a rough draft of the agency's upcoming final guidance on health claim substantiation, according to the Center for Food Safety & Nutrition's Barbara Schneeman, PhD
You may also be interested in...
FDA Tackles Observational Studies In Draft Health Claims Guidance
"Scientific conclusions from observational studies cannot be drawn about a relationship between a food component and a disease," FDA concludes in draft guidance for health claim petitioners
Qualified Health Claim Study Should Test Letter Grades, SSA Claims – CHPA
FDA should study consumer perceptions of qualified health claims by testing statements that contain both "report card" grades and text ratings, as well as claims that do not bear a letter grade, the Consumer Healthcare Products Association says in recent comments to the agency
Lawsuit Will Question Supplement Exclusion From Lycopene/Cancer Claims
American Longevity will file a lawsuit against FDA no later than Dec. 9 in response to the agency's denial of qualified health claims tying lycopene-containing dietary supplements to cancer risk reduction